BLSIF (Britannia Life Sciences) 3-Year Book Growth Rate: 43.90% (As of Mar. 2026) — 23% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Britannia Life Sciences 3-Year Book Growth Rate?

Britannia Life Sciences BLSIF 3-Year Book Growth Rate is 43.90% as of Mar. 2026, which is 23% below its 10-year median of 56.75. The stock has 5 warning signs investors should review. Among 1,129 Biotechnology companies, Britannia Life Sciences ranks better than 92.83% on this metric.

Britannia Life Sciences's Book Value per Share for the quarter that ended in Mar. 2026 was $0.09.

During the past 12 months, Britannia Life Sciences's average Book Value per Share Growth Rate was 228.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was 43.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 6 years, the highest 3-Year average Book Value per Share Growth Rate of Britannia Life Sciences was 69.60% per year. The lowest was 43.90% per year. And the median was 56.75% per year.


Britannia Life Sciences  (OTCPK:BLSIF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Britannia Life Sciences 3-Year Book Growth Rate Related Terms


BLSIF vs VRTX, REGN, MRNA: 3-Year Book Growth Rate Comparison

For the Biotechnology subindustry, Britannia Life Sciences's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Britannia Life Sciences 3-Year Book Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Britannia Life Sciences's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Britannia Life Sciences's 3-Year Book Growth Rate falls into.



Britannia Life Sciences 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

What does a 3-Year Book Growth Rate of 43.90% mean?
Britannia Life Sciences (BLSIF) has a 3-Year Book Growth Rate of 43.90% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Britannia Life Sciences and its competitors. This is 23% below median its historical median of 56.75. Over the past decade, Britannia Life Sciences' 3-Year Book Growth Rate has ranged from 43.90 to 69.60. According to the industry distribution chart, Britannia Life Sciences ranks #81 out of 1129 companies in the Biotechnology industry, placing it in the top 7.2%.
Is Britannia Life Sciences' 3-Year Book Growth Rate too high?
Britannia Life Sciences' current 3-Year Book Growth Rate of 43.90% is 23% below median its 10-year median of 56.75. Over the past 10 years, this metric has ranged from a low of 43.90 to a high of 69.60. Based on the distribution chart, Britannia Life Sciences ranks #81 out of 1129 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Britannia Life Sciences' 3-Year Book Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Britannia Life Sciences ranks #81 out of 1129 companies for 3-Year Book Growth Rate. This places Britannia Life Sciences in the top 7% of its industry — outperforming the majority of peers. Historically, Britannia Life Sciences' own 3-Year Book Growth Rate has ranged from 43.90 to 69.60 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Biotechnology company?
A good 3-Year Book Growth Rate depends on the Biotechnology industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Britannia Life Sciences and its competitors. Britannia Life Sciences's current 3-Year Book Growth Rate is 43.90%, which is 23% below median its own 10-year median of 56.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Britannia Life Sciences stock overvalued right now?
Britannia Life Sciences (BLSIF) has a current 3-Year Book Growth Rate of 43.90%. The current 3-Year Book Growth Rate is 43.90%, which is 23% below median its 10-year median of 56.75. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Britannia Life Sciences (BLSIF), the current 3-Year Book Growth Rate is 43.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Britannia Life Sciences Business Description

Other Exchanges BLAB:Canada
Address 120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc provides product testing, safety assessment, and manufacturing services to the cosmetic and consumer packaged goods industries in the United Kingdom and globally.